Thiocolchicoside is a muscle relaxant drug with analgesic and anti-inflammatory effects. It is a naturally occurring glucoside from a plant source and is commonly used to relieve painful muscle contractions, muscle stiffness, joint, & nerve diseases, and low backache in adults including adolescents above the age of sixteen years. It works on the centers in spinal cord and brain to relieve muscle stiffness without decreasing strength. This drug is available in ointment, tablet, and injection forms. The side effects of thiocolchicoside includes allergy, sleepiness, nausea, and vasovagal reactions. It can also cause headache, itching & skin rash, and swelling of face, lips, eyelids, etc. This medicine is not suggested for the patients those are allergic to thiocolchicoside or any other inactive ingredient existing along with it. 

Market Dynamics

Thiocolchicoside is mainly used for muscle relaxation which relives painful spams of skeletal muscles. Thus, increasing number of aged population and rise in the use of thiocolchicoside among this age group are anticipated to drive the demand throughout the forecast period. Along with muscle relaxation, it is also used for joint diseases, osteoarthritis, rheumatoid arthritis, and ischiadynia, etc. which is expected to increase the demand for this drug during the forecast period. It is a safe medicine if used as per doctor’s prescription and for advised duration. Recently, it is stated that high doses of thiocolchicoside may damage male fertility, harm to unborn child, and can cause a risk of cancer. Thus, aforementioned side-effects of thiocolchicoside may hamper the market growth over the forecast period.

Market Classification and Overview

The global thiocolchicoside market is bifurcated on the basis of type, application and geography. On the basis of type, the market is classified into injection, tablet, and others. The global thiocolchicoside market is also segmented based on application as antispasmodics, anti-gout, and others.

Regional Overview

The market for thiocolchicoside is segmented into regions such as North America, Europe, Asia-Pacific, Latin America, and Middle-East and Africa (MEA). Asia-Pacific was the major contributor to the growth of thiocolchicoside market in 2015, owing to the increase in population, particularly ageing and working population. Europe is also anticipated to hold a significant share in the global market followed by North America. Thiocolchicoside is authorized through national procedures in Greece, France, Italy, France, Portugal, and Spain.

Report Coverage

Market Participants

Alchem International, Indena Spa, Reva Pharma, Yeshua Pharma, Nuova Linnea, Alkaloids Corporation, Alapati Pharma, Lupin, Nobel Pharmaceuticals, Mylan Spa, and Alaina Pharma are the key players in the thiocolchicoside market.

Market Segmentation

Market By Product

·         Injection

·         Tablet

·         Other

Market By Application

·         Antispasmodics

·         Anti-Gout

·         Other

Market By Geography

·         North America

o   US

o   Canada

o   Mexico

·         Europe

o   UK

o   Germany

o   France

o   Rest of Europe

·         Asia-Pacific

o   China

o   Japan

o   India

o   Australia

o   Rest of Asia-Pacific

·         Latin America

o   Brazil

o   Rest of Latin America

·         Middle East and Africa (MEA)

o   South Africa

o   Saudi Arabia

o   Rest of MEA